Amyloidosis is a systemic disease characterized by extracellular deposits of insoluble
amyloid in various tissues and organs. Cardiac amyloidosis is a frequent feature of the …

Cardiac amyloidosis is a rare, debilitating, and usually fatal disease increasingly recognized
in clinical practice despite patients presenting with non-specific symptoms of …

Cardiac Amyloidosis (CA) is a toxic infiltrative cardiomyopathy occurred by the deposition of
the amyloid fibres in the extracellular matrix of the myocardium. This results in severe clinical …

Background Bacterial pneumonia and sepsis are both common causes of end-organ
dysfunction, especially in immunocompromised and critically ill patients. Pre-clinical data …

Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment | Current Heart
Failure Reports Skip to main content SpringerLink Account Menu Find a journal Publish with us …

Amyloidosis is a disease characterized by the deposition of protein fibrils. Cardiac
involvement is a significant factor in determining prognosis. This study aimed to examine the …

Cardiac amyloidosis (CA) represents an emerging challenge in cardiovascular medicine,
with notable clinical overlaps and diagnostic complexities when coexisting with coronary …

The study demonstrates how technology has had a dramatic influence on healthcare,
allowing for the analysis of large clinical datasets using machine learning for early illness …

Background: Amyloidosis is a major long-term complication of chronic disease; however,
whether it represents one of the complications of post-myocardial infarction (MI) is yet to be …

There are various machine learning models for medical treatment that are now in use,
however they all primarily target identifying a single condition. Consequently, this study has …